The Ovarian Tumor Tissue Analysis Consortium investigated the prognostic impact of ER and PR expression specifically in EnOC, where investigators used a three-tier taxonomy for quantifying expression magnitude, reporting a survival benefit in ER-positive and PR-positive cases [21], which was mirrored in an independent study of from Rambau et al. The gene discussed is ESR1; the disease is ovarian neoplasm.